hato yukari

ハトユカリ | hato yukari

Research field (1)： Tumor diagnostics and therapeutics

Research theme for competitive and other funds (2)：

2018 - 2021 RNF5, a molecule that induces autophagy, and chemotherapy resistance in breast cancer
2015 - 2018 Treatment strategy of breast cancer using micro RNA-1290

Papers (45)：

Naomi Gondo, Yasuhiro Sakai, Zhenhuan Zhang, Yukari Hato, Kiyotaka Kuzushima, Suchada Phimsen, Yoshiaki Kawashima, Makoto Kuroda, Motoshi Suzuki, Seiji Okada, et al. Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas. Laboratory investigation; a journal of technical methods and pathology. 2021. 101. 8. 1048-1059
鎗山憲人, 杉浦博士, 波戸ゆかり, 松本奈々, 山中菜摘, 羽喰英美, 伊藤由加志, 安藤由明. 当院で経験した肉芽腫生乳腺炎4例の治療検討. 日本臨床外科学会雑誌. 2019. 80. 増刊. 555-555
羽喰英美, 波戸ゆかり, 鎗山憲人, 山中菜摘, 松本奈々, 杉浦博士. 放射線治療を契機に腫瘍崩壊症候群を呈した進行乳癌の一例. 日本臨床外科学会雑誌. 2019. 80. 増刊. 745-745
Nishimoto M, Nishikawa S, Kondo N, Wanifuchi-Endo Y, Hato Y, Hisada T, Dong Y, Okuda K, Sugiura H, Kato H, et al. Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients. Japanese journal of clinical oncology. 2019. 49. 6. 567-575
Wanifuchi-Endo Y, Asano T, Kondo N, Hato Y, Dong Y, Hisada T, Nishikawa S, Kato H, Takahashi S, Okuda K, et al. Effects of serum estradiol and progesterone on estrogen-regulated gene expression in breast cancers of premenopausal patients. Japanese journal of clinical oncology. 2019. 49. 1. 12-21

ｍore...

MISC (10)：

Y. Endo, Y. Dong, N. Kondo, Y. Hato, T. Hisada, M. Nishimoto, S. Nishikawa, S. Takahashi, T. Toyama. Exome sequencing of human breast cancer tissues resistant to taxanes. CANCER RESEARCH. 2017. 77
N. Kondo, T-S Kim, Y. Wanifuchi, Y. Hato, T. Hisada, M. Nishimoto, S. Nishikawa, T. Toyama. The prognostic impact of inositol polyphosphate 5-phosphatase PIPP (INPP5J) expression in breast cancer tissue. CANCER RESEARCH. 2017. 77
Yukari Hato, Yumi Endo, Nobuyasu Yoshimoto, Tomoko Asano, Mina Yamaguchi, Satoru Takahashi, Tatsuya Toyama. Prognostic impact of single-nucleotide polymorphisms (SNPs) in or near the ZNF423 and CTSO genes in estrogen receptor (ER) - positive breast cancer patients receiving adjuvant endocrine therapy. CANCER RESEARCH. 2015. 75
Tatsuya Toyama, Tomoko Asano, Shinya Sato, Nobuyasu Yoshimoto, Yumi Endo, Yukari Hato, Dong Yu, Satoru Takahashi, Yoshitaka Fujii. High expression of LMTK3 is an independent factor indicating a poor prognosis in Japanese estrogen receptor alpha-positive breast cancer patients. CANCER RESEARCH. 2015. 75
Yumi Endo, Hiroko Yamashita, Satoru Takahashi, Shinya Sato, Nobuyasu Yoshimoto, Tomoko Asano, Yukari Hato, Mina Yamaguchi, Yu Dong, Tatsuya Toyama. Immunohistochemical determination of arylamine N-acetyltransferase 1 (NAT1) as the target of miR-1290 and prognostic biomarker of breast cancer. CANCER RESEARCH. 2015. 75

ｍore...

Professional career (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page